New Eli Lilly weight loss drug has dramatic effects in clinical trial

Published Updated



An experimental anti-obesity injection helped patients reach new levels of weight loss previously only achievable through bariatric surgery, according to new data from the pharmaceutical giant Eli Lilly. 

The new medication, retatrutide, appears to be the most powerful medication of its kind in a wave of injections and pills that have transformed obesity and diabetes management in recent years. 

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.